US EditionChampioning access to core palliative care medicines for people receiving end-of-life care - Pharmaceutical Society of Australia
Summary by Pharmaceutical Society of Australia
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Championing access to core palliative care medicines for people receiving end-of-life care - Pharmaceutical Society of Australia
8 May 2025 The Pharmaceutical Society of Australia (PSA) is continuing its leadership in quality use of medicines as part of a new consortium led by Palliative Care Australia, set to deliver targeted education to prescribers, pharmacists and aged care nurses on critical palliative medicines. Supported by the Australian Government’s Quality Use of Diagnostics, Therapeutics and Pathology (QUDTP) Program, the Quality Use of Community Palliative…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
